Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000202490> ?p ?o ?g. }
- W2000202490 endingPage "e39656" @default.
- W2000202490 startingPage "e39656" @default.
- W2000202490 abstract "Chronic hyperglycemia-associated inflammation plays critical roles in disease initiation and the progression of diabetic complications, including Alzheimer's disease (AD). However, the association of chronic hyperglycemia with acute inflammation of the central nervous system in the progression of AD still needs to be elucidated. In addition, recent evidence suggests that Glucagon-like peptide-1 receptor (GLP-1R) protects against neuronal damage in the brain. Therefore, the neuroprotective effects of the GLP-1R agonist exendin-4 (EX-4) against hyperglycemia/lipopolysaccharides (LPS) damage were also evaluated in this study.Ten days after streptozotocin (STZ) or vehicle (sodium citrate) treatment in mice, EX-4 treatment (10 µg/kg/day) was applied to the mice before intrahippocampal CA1 injection of LPS or vehicle (saline) and continued for 28 days. This study examined the molecular alterations in these mice after LPS and EX4 application, respectively. The mouse cognitive function was evaluated during the last 6 days of EX-4 treatment. The results showed that the activation of NF-κB-related inflammatory responses induced cognitive dysfunction in both the hyperglycemic mice and the mice that received acute intrahippocampal LPS injection. Furthermore, acute intrahippocampal LPS injection exacerbated the impairment of spatial learning and memory through a strong decrease in monoaminergic neurons and increases in astrocytes activation and apoptosis in the hyperglycemic mice. However, EX-4 treatment protected against the cognitive dysfunction resulting from hyperglycemia or/and intrahippocampal LPS injection.These findings reveal that both hyperglycemia and intrahippocampal LPS injection induced cognitive dysfunction via activation of NF-κB-related inflammatory responses. However, acute intrahippocampal LPS injection exacerbated the progression of cognitive dysfunction in the hyperglycemic mice via a large increase in astrocytes activation-related responses. Furthermore, EX-4 might be considered as a potential adjuvant entity to protect against neurodegenerative diseases." @default.
- W2000202490 created "2016-06-24" @default.
- W2000202490 creator A5010471217 @default.
- W2000202490 creator A5033780365 @default.
- W2000202490 creator A5055040918 @default.
- W2000202490 creator A5057431197 @default.
- W2000202490 creator A5066656836 @default.
- W2000202490 creator A5068843420 @default.
- W2000202490 creator A5080803226 @default.
- W2000202490 creator A5081298895 @default.
- W2000202490 date "2012-07-23" @default.
- W2000202490 modified "2023-10-16" @default.
- W2000202490 title "Exendin-4 Protected against Cognitive Dysfunction in Hyperglycemic Mice Receiving an Intrahippocampal Lipopolysaccharide Injection" @default.
- W2000202490 cites W147870220 @default.
- W2000202490 cites W1721598185 @default.
- W2000202490 cites W1784761870 @default.
- W2000202490 cites W1965942744 @default.
- W2000202490 cites W1976451610 @default.
- W2000202490 cites W1977239057 @default.
- W2000202490 cites W1977951553 @default.
- W2000202490 cites W1986384924 @default.
- W2000202490 cites W1989709638 @default.
- W2000202490 cites W1990441398 @default.
- W2000202490 cites W1992723640 @default.
- W2000202490 cites W1993376226 @default.
- W2000202490 cites W1997215875 @default.
- W2000202490 cites W2000115601 @default.
- W2000202490 cites W2008789293 @default.
- W2000202490 cites W2009200525 @default.
- W2000202490 cites W2012829023 @default.
- W2000202490 cites W2012947457 @default.
- W2000202490 cites W2016187305 @default.
- W2000202490 cites W2017666196 @default.
- W2000202490 cites W2021035318 @default.
- W2000202490 cites W2027755570 @default.
- W2000202490 cites W2027862307 @default.
- W2000202490 cites W2036735444 @default.
- W2000202490 cites W2045846363 @default.
- W2000202490 cites W2046454316 @default.
- W2000202490 cites W2051462201 @default.
- W2000202490 cites W2053557703 @default.
- W2000202490 cites W2053818485 @default.
- W2000202490 cites W2055667558 @default.
- W2000202490 cites W2055750901 @default.
- W2000202490 cites W2059744535 @default.
- W2000202490 cites W2061419556 @default.
- W2000202490 cites W2063086502 @default.
- W2000202490 cites W2069796133 @default.
- W2000202490 cites W2070316201 @default.
- W2000202490 cites W2074256095 @default.
- W2000202490 cites W2082461385 @default.
- W2000202490 cites W2089784089 @default.
- W2000202490 cites W2090464516 @default.
- W2000202490 cites W2094544734 @default.
- W2000202490 cites W2094788265 @default.
- W2000202490 cites W2101333119 @default.
- W2000202490 cites W2109164958 @default.
- W2000202490 cites W2114324710 @default.
- W2000202490 cites W2117437970 @default.
- W2000202490 cites W2130533170 @default.
- W2000202490 cites W2140625608 @default.
- W2000202490 cites W2141082261 @default.
- W2000202490 cites W2141268423 @default.
- W2000202490 cites W2149502431 @default.
- W2000202490 cites W2160574753 @default.
- W2000202490 cites W2161722802 @default.
- W2000202490 cites W2162709320 @default.
- W2000202490 cites W2168451388 @default.
- W2000202490 cites W2168530623 @default.
- W2000202490 doi "https://doi.org/10.1371/journal.pone.0039656" @default.
- W2000202490 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3402484" @default.
- W2000202490 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22844396" @default.
- W2000202490 hasPublicationYear "2012" @default.
- W2000202490 type Work @default.
- W2000202490 sameAs 2000202490 @default.
- W2000202490 citedByCount "56" @default.
- W2000202490 countsByYear W20002024902013 @default.
- W2000202490 countsByYear W20002024902014 @default.
- W2000202490 countsByYear W20002024902015 @default.
- W2000202490 countsByYear W20002024902016 @default.
- W2000202490 countsByYear W20002024902017 @default.
- W2000202490 countsByYear W20002024902018 @default.
- W2000202490 countsByYear W20002024902019 @default.
- W2000202490 countsByYear W20002024902020 @default.
- W2000202490 countsByYear W20002024902021 @default.
- W2000202490 countsByYear W20002024902022 @default.
- W2000202490 countsByYear W20002024902023 @default.
- W2000202490 crossrefType "journal-article" @default.
- W2000202490 hasAuthorship W2000202490A5010471217 @default.
- W2000202490 hasAuthorship W2000202490A5033780365 @default.
- W2000202490 hasAuthorship W2000202490A5055040918 @default.
- W2000202490 hasAuthorship W2000202490A5057431197 @default.
- W2000202490 hasAuthorship W2000202490A5066656836 @default.
- W2000202490 hasAuthorship W2000202490A5068843420 @default.
- W2000202490 hasAuthorship W2000202490A5080803226 @default.
- W2000202490 hasAuthorship W2000202490A5081298895 @default.
- W2000202490 hasBestOaLocation W20002024901 @default.
- W2000202490 hasConcept C126322002 @default.